SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-136733
Filing Date
2022-05-02
Accepted
2022-05-02 16:04:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d236526ddefa14a.htm DEFA14A 11563
2 GRAPHIC g236526g00n14.jpg GRAPHIC 209457
3 GRAPHIC g236526g00n15.jpg GRAPHIC 65837
  Complete submission text file 0001193125-22-136733.txt   378973
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38541 | Film No.: 22881865
SIC: 2834 Pharmaceutical Preparations